Firm launches two stem cell trials against blindness
Crossposted from Nature’s news blog on behalf of Meredith Wadman Geron made medical history last October, when it treated subject number one in the first-ever trial of a human embryonic stem cell (hESC) therapy, for spinal cord injury. Now, the second and third hESC trials have been launched. On July 12, in an operating room at the University of California, Los Angeles, the first subject in each of the trials — one for a rare form of blindness that usually begins in childhood, the other for a common cause of blindness in the elderly — was treated with retinal pigment … Read more
Recent comments
Real-time tissue analysis could guide brain tumor surgery
Bundled RNA balls silence brain cancer gene expression
Ebola outbreak in West Africa lends urgency to recently-funded research